Episodio 1 de ReumaGuardiaReferencias https://www.the-rheumatologist.org/issue/march-2023/vacunación articulo rheumatologist https://www.the-rheumatologist.org/article/acr-releases-new-vaccination-guideline/ Resumen 2023 rheumatologist https://www.the-rheumatologist.org/article/clinical-rheumatology-year-in-review-2022/ alerta denosumab rheumatologisthttps://www.the-rheumatologist.org/article/patients-on-dialysis-taking-denosumab-may-be-at-risk-of-severe-hypocalcemia/ Revisión entesitis Arthritis and rheumatologyhttps://onlinelibrary.wiley.com/toc/23265205/2023/75/4Editorial tocilizumabhttps://onlinelibrary.wiley.com/doi/10.1002/art.42299 https://onlinelibrary.wiley.com/doi/10.1002/art.42414 Diagnóstico pirofosfato de calcio https://onlinelibrary.wiley.com/doi/10.1002/art.42368 Nefritis lúpica ciudad de Nueva York https://onlinelibrary.wiley.com/doi/10.1002/art.42375 Tocilizumab en ACG efecto hemoglobina glicada https://onlinelibrary.wiley.com/doi/10.1002/art.42405 https://onlinelibrary.wiley.com/toc/25785745/2023/5/3ACR open https://onlinelibrary.wiley.com/doi/10.1002/acr2.11518Osteoartrosis y obesidad y síndrome metabólico hombre y mujer Cambios cognitivos en pacientes con lupus https://onlinelibrary.wiley.com/doi/10.1002/acr2.11529 Efecto multidominio guselkumab https://onlinelibrary.wiley.com/doi/10.1002/acr2.11523 https://rmdopen.bmj.com/SAF triple positivo perfil https://rmdopen.bmj.com/content/9/1/e002534 Cohorte francesa caracterización de pacientes con SAFhttps://rmdopen.bmj.com/content/9/1/e002881 Annals of rheumatic disease https://ard.bmj.com/content/82/4?current-issue=y vacunación y secuelas postagudas de covid https://ard.bmj.com/content/82/4/565 Progresión radiográfica de pacientes con espondilo, factores de riesgo genético https://ard.bmj.com/content/82/4/527 Factores de riesgo uso prolongado de esteroides en terapia puente https://ard.bmj.com/content/82/4/468 Esclerosis sistémica sin esclerodermiahttps://rmdopen.bmj.com/content/9/1/e002890.long